Home News

First quarter 2019 results presentation

Operating income, growth figures, profitability and how our products have behaved

Wed, 08/05/2019 - 12:15 0 min
Download related document
No votes yet
 
Related
ROVI takes first place in the Sustainalytics world ESG risk ranking for the...
  ROVI takes first place in the Sustainalytics world ESG risk ranking for the second year running Laboratorios Farmacéuticos...
3 min
04/08/2023
ROVI informs on the evaluation process to obtain marketing authorisation for...
ROVI informs on the evaluation process to obtain marketing authorisation for Risvan® The United States Food and Drug Administration (...
1 min
28/07/2023
First half 2023 results press release
ROVI ACHIEVED STABLE TOTAL REVENUE OF 381.0 MILLION EUROS IN THE FIRST POST-PANDEMIC HALF YEAR Operating revenue remained stable,...
4 min
26/07/2023